| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |